Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Clinical trial NCT06376097 · RECRUITING
Trial details
- NCT number
- NCT06376097
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-04-19
- Primary completion
- 2026-11-29
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.